Mercer Global Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,550
| Closed | -$10K | – | 1942 |
|
|
2023
Q1 | $10K | Hold |
10,550
| – | – | ﹤0.01% | 1914 |
|
|
2022
Q4 | $9K | Hold |
10,550
| – | – | ﹤0.01% | 1915 |
|
|
2022
Q3 | $9K | Hold |
10,550
| – | – | ﹤0.01% | 1806 |
|
|
2022
Q2 | $10K | Hold |
10,550
| – | – | ﹤0.01% | 1812 |
|
|
2022
Q1 | $17K | Hold |
10,550
| – | – | ﹤0.01% | 1857 |
|
|
2021
Q4 | $25K | Buy |
10,550
+50
| +0.5% | +$118 | ﹤0.01% | 1773 |
|
|
2021
Q3 | $51K | Hold |
10,500
| – | – | ﹤0.01% | 1716 |
|
|
2021
Q2 | $28K | Hold |
10,500
| – | – | ﹤0.01% | 1652 |
|
|
2021
Q1 | $32K | Buy |
+10,500
| New | +$32K | ﹤0.01% | 1590 |
|